WINNIPEG, MANITOBA -- (MARKET WIRE) -- May 14, 2007 -- Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, has been awarded Patent No. 2,452,032 to protect compositions and methods of inhibiting biofilm formation in a variety of applications, including medical devices. The patent, entitled "Synergistic Antimicrobial Compositions and Methods of Inhibiting Biofilm Formation", has been awarded by the Canadian Intellectual Property Office.
